MBX Biosciences, Inc. MBX Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s accrued expenses?
- MBX Biosciences, Inc. (MBX) reported accrued expenses of $7.42M in Q1 2026.
- How has MBX Biosciences, Inc.'s accrued expenses changed year-over-year?
- MBX Biosciences, Inc.'s accrued expenses increased by 21.4% year-over-year, from $6.11M to $7.42M.
- What is the long-term trend for MBX Biosciences, Inc.'s accrued expenses?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s accrued expenses has grown at a 127.7% compound annual growth rate (CAGR), from $2.38M to $12.35M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.